Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7691856rdf:typepubmed:Citationlld:pubmed
pubmed-article:7691856lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0373440lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0459522lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C1280879lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0007818lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0132555lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0428714lld:lifeskim
pubmed-article:7691856lifeskim:mentionsumls-concept:C0599946lld:lifeskim
pubmed-article:7691856pubmed:issue6lld:pubmed
pubmed-article:7691856pubmed:dateCreated1993-11-12lld:pubmed
pubmed-article:7691856pubmed:abstractTextStimulation of cerebrovascular parasympathetic nerves markedly increases cortical blood flow. Nitric oxide (NO) or a NO-containing compound is present in these nerves and may therefore, upon release, be partly responsible for the flow increase. In addition, transmitters released from the nerves may cause synthesis and release of this compound from the endothelium. The contribution of NO synthesis to the cortical blood flow (CoBF) increase during parasympathetic stimulation was elucidated in rat by laser-Doppler flowmetry. Thirty-minute exposure to circulating N omega-nitro-L-arginine methyl ester (L-NAME) 50 mg kg-1 eliminated most of the response (from 104 to 8% increase), whereas 10-min exposure to this dose or 30-min exposure to 5 mg kg-1 caused a less marked reduction. The reducing effect was particularly evident after elimination of the systemic blood pressure increase caused by L-NAME (only 3% increase after the high dose). Infusion of L-arginine restored the flow response. Resting CoBF was not substantially affected by blockade of NO formation. Thus, release of an NO-containing compound constitutes a major component of the increase in CoBF caused by parasympathetic nerve stimulation but does not seem to contribute to cortical flow regulation during resting conditions.lld:pubmed
pubmed-article:7691856pubmed:languageenglld:pubmed
pubmed-article:7691856pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7691856pubmed:citationSubsetIMlld:pubmed
pubmed-article:7691856pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7691856pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7691856pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7691856pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7691856pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7691856pubmed:statusMEDLINElld:pubmed
pubmed-article:7691856pubmed:monthNovlld:pubmed
pubmed-article:7691856pubmed:issn0271-678Xlld:pubmed
pubmed-article:7691856pubmed:authorpubmed-author:HardeboJ EJElld:pubmed
pubmed-article:7691856pubmed:authorpubmed-author:BouskelaEElld:pubmed
pubmed-article:7691856pubmed:authorpubmed-author:Morita-Tsuzuk...lld:pubmed
pubmed-article:7691856pubmed:issnTypePrintlld:pubmed
pubmed-article:7691856pubmed:volume13lld:pubmed
pubmed-article:7691856pubmed:ownerNLMlld:pubmed
pubmed-article:7691856pubmed:authorsCompleteYlld:pubmed
pubmed-article:7691856pubmed:pagination993-7lld:pubmed
pubmed-article:7691856pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:meshHeadingpubmed-meshheading:7691856-...lld:pubmed
pubmed-article:7691856pubmed:year1993lld:pubmed
pubmed-article:7691856pubmed:articleTitleInhibition of nitric oxide synthase attenuates the cerebral blood flow response to stimulation of postganglionic parasympathetic nerves in the rat.lld:pubmed
pubmed-article:7691856pubmed:affiliationDepartment of Medical Cell Research, University of Lund, Sweden.lld:pubmed
pubmed-article:7691856pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7691856pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7691856lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7691856lld:pubmed